27 Objective Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 2026/2027 | Page 1 | Passing Sc
WESTERN GOVERNORS UNIVERSITY
WGU D027 Objective Assessment Review (Latest 2026/2027 Update)
Advanced Pathopharmacological Foundations| Questions and Verified
Answers| 100% Correct| Grade A 2026/2027
ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS · Official Exam 2026/2027
100 80% CERTIFIED
QUESTIONS PASSING SCORE RECERTIFICATION
TABLE OF CONTENTS
Section 1 Advanced Pharmacology Principles Q1-Q20
Section 2 Pathophysiology of Major Organ Systems Q21-Q40
Section 3 Pharmacotherapy for Chronic Conditions Q41-Q60
Section 4 Drug Interactions and Adverse Effects Q61-Q80
Section 5 Evidence-Based Pharmacological Practice Q81-Q100
Instructions: Select the single best answer for each question. This exam is designed for WGU D027 Advanced Pathopharmacological
Foundations objective assessment preparation. Passing score: 80% (80 questions correct).
ve Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 - 2026/2027 | Passing Score: 8
,inciples | Q1-Q20 | WGU D027 Objective Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 10
Q1 Question 1 of 100
A 54-year-old patient with hypertension is prescribed a drug that acts as a competitive antagonist at
alpha-1 adrenergic receptors. The nurse understands that this medication will produce which primary
therapeutic effect?
A. Vasodilation and decreased peripheral resistance
B. Increased heart rate and contractility
C. Bronchoconstriction and increased airway resistance
D. Increased renin release from the kidneys
Correct Answer: A
Rationale:
Alpha-1 adrenergic antagonists block vasoconstriction, resulting in vasodilation and decreased peripheral resistance,
which lowers blood pressure. Increased heart rate is not a direct therapeutic effect but may occur as a reflex
response to hypotension.
Q2 Question 2 of 100
A pharmacist explains to a nursing student that a drug with a high first-pass effect will likely require which
adjustment when switching from oral to intravenous administration?
A. Decreasing the IV dose compared to the oral dose
B. Increasing the IV dose compared to the oral dose
C. Keeping the IV dose the same as the oral dose
D. Administering the IV dose more frequently than the oral dose
Correct Answer: A
Rationale:
Drugs with high first-pass metabolism are largely inactivated by the liver before reaching systemic circulation when
taken orally. When given intravenously, the drug bypasses first-pass metabolism, so a lower dose is needed to
achieve the same therapeutic effect.
ve Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 - 2026/2027 | Passing Score: 8
, Q3 Question 3 of 100
A patient receives a medication that binds to a receptor and produces a maximal biological response.
The nurse identifies this medication as which type of agonist?
A. Full agonist
B. Partial agonist
C. Competitive antagonist
D. Inverse agonist
Correct Answer: A
Rationale:
A full agonist binds to a receptor and produces the maximal biological response possible. A partial agonist produces
a submaximal response even at full receptor occupancy, while a competitive antagonist blocks the receptor without
activating it.
Q4 Question 4 of 100
A clinical trial shows that a new drug has a therapeutic index of 5, while a commonly used alternative has
a therapeutic index of 25. The nurse understands that the new drug has which characteristic compared to
the alternative?
A. A narrower margin of safety
B. A wider margin of safety
C. Greater efficacy at lower doses
D. Faster onset of action
Correct Answer: A
Rationale:
The therapeutic index is the ratio of the toxic dose to the therapeutic dose; a lower therapeutic index indicates a
narrower margin of safety. The new drug with a TI of 5 has a much narrower safety margin than the alternative with a
TI of 25.
Q5 Question 5 of 100
A patient with chronic pain is taking morphine and develops tolerance to the analgesic effect. The nurse
understands that pharmacodynamic tolerance is primarily caused by which mechanism?
A. Downregulation of opioid receptors in the central nervous system
B. Increased metabolic breakdown of the drug
C. Enhanced renal elimination of the drug
D. Decreased gastrointestinal absorption of the drug
Correct Answer: A
Rationale:
Pharmacodynamic tolerance results from downregulation or desensitization of receptors in response to chronic drug
exposure, requiring higher doses to achieve the same effect. Increased metabolic breakdown would represent
pharmacokinetic tolerance, not pharmacodynamic.
ve Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 - 2026/2027 | Passing Score: 8
, Q6 Question 6 of 100
A nurse is reviewing a patient's medication list and notes that Drug A is a CYP3A4 inhibitor while Drug B
is metabolized by CYP3A4. The nurse anticipates that concurrent administration will result in which
effect?
A. Increased levels of Drug B
B. Decreased levels of Drug B
C. No change in Drug B levels
D. Rapid elimination of Drug B
Correct Answer: A
Rationale:
A CYP3A4 inhibitor reduces the metabolic breakdown of drugs that depend on CYP3A4 for elimination, leading to
increased plasma levels of Drug B and potential toxicity. This is a common and clinically significant drug-drug
interaction.
Q7 Question 7 of 100
A patient is prescribed a medication with a half-life of 12 hours. The nurse understands that
approximately how long it will take to reach steady-state plasma concentrations with regular dosing?
A. 12 hours
B. 24 hours
C. 48 hours
D. 60 hours
Correct Answer: D
Rationale:
Steady-state plasma concentration is reached after approximately 4-5 half-lives of regular dosing. With a half-life of
12 hours, steady state would be reached in approximately 48-60 hours (4-5 x 12). The most accurate answer of the
choices is 60 hours.
Q8 Question 8 of 100
A nursing student asks why some drugs are administered as prodrugs. The instructor explains that
prodrugs are designed to serve which primary purpose?
A. To improve drug absorption, distribution, or targeting by becoming active after metabolism
B. To increase drug toxicity for enhanced therapeutic effect
C. To bypass all metabolic processes entirely
D. To reduce manufacturing costs of the medication
Correct Answer: A
Rationale:
Prodrugs are pharmacologically inactive compounds that are converted to active drugs through metabolic processes
in the body. This approach improves drug absorption, reduces side effects, or enables targeted delivery to specific
tissues.
ve Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 - 2026/2027 | Passing Score: 8
WESTERN GOVERNORS UNIVERSITY
WGU D027 Objective Assessment Review (Latest 2026/2027 Update)
Advanced Pathopharmacological Foundations| Questions and Verified
Answers| 100% Correct| Grade A 2026/2027
ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS · Official Exam 2026/2027
100 80% CERTIFIED
QUESTIONS PASSING SCORE RECERTIFICATION
TABLE OF CONTENTS
Section 1 Advanced Pharmacology Principles Q1-Q20
Section 2 Pathophysiology of Major Organ Systems Q21-Q40
Section 3 Pharmacotherapy for Chronic Conditions Q41-Q60
Section 4 Drug Interactions and Adverse Effects Q61-Q80
Section 5 Evidence-Based Pharmacological Practice Q81-Q100
Instructions: Select the single best answer for each question. This exam is designed for WGU D027 Advanced Pathopharmacological
Foundations objective assessment preparation. Passing score: 80% (80 questions correct).
ve Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 - 2026/2027 | Passing Score: 8
,inciples | Q1-Q20 | WGU D027 Objective Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 10
Q1 Question 1 of 100
A 54-year-old patient with hypertension is prescribed a drug that acts as a competitive antagonist at
alpha-1 adrenergic receptors. The nurse understands that this medication will produce which primary
therapeutic effect?
A. Vasodilation and decreased peripheral resistance
B. Increased heart rate and contractility
C. Bronchoconstriction and increased airway resistance
D. Increased renin release from the kidneys
Correct Answer: A
Rationale:
Alpha-1 adrenergic antagonists block vasoconstriction, resulting in vasodilation and decreased peripheral resistance,
which lowers blood pressure. Increased heart rate is not a direct therapeutic effect but may occur as a reflex
response to hypotension.
Q2 Question 2 of 100
A pharmacist explains to a nursing student that a drug with a high first-pass effect will likely require which
adjustment when switching from oral to intravenous administration?
A. Decreasing the IV dose compared to the oral dose
B. Increasing the IV dose compared to the oral dose
C. Keeping the IV dose the same as the oral dose
D. Administering the IV dose more frequently than the oral dose
Correct Answer: A
Rationale:
Drugs with high first-pass metabolism are largely inactivated by the liver before reaching systemic circulation when
taken orally. When given intravenously, the drug bypasses first-pass metabolism, so a lower dose is needed to
achieve the same therapeutic effect.
ve Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 - 2026/2027 | Passing Score: 8
, Q3 Question 3 of 100
A patient receives a medication that binds to a receptor and produces a maximal biological response.
The nurse identifies this medication as which type of agonist?
A. Full agonist
B. Partial agonist
C. Competitive antagonist
D. Inverse agonist
Correct Answer: A
Rationale:
A full agonist binds to a receptor and produces the maximal biological response possible. A partial agonist produces
a submaximal response even at full receptor occupancy, while a competitive antagonist blocks the receptor without
activating it.
Q4 Question 4 of 100
A clinical trial shows that a new drug has a therapeutic index of 5, while a commonly used alternative has
a therapeutic index of 25. The nurse understands that the new drug has which characteristic compared to
the alternative?
A. A narrower margin of safety
B. A wider margin of safety
C. Greater efficacy at lower doses
D. Faster onset of action
Correct Answer: A
Rationale:
The therapeutic index is the ratio of the toxic dose to the therapeutic dose; a lower therapeutic index indicates a
narrower margin of safety. The new drug with a TI of 5 has a much narrower safety margin than the alternative with a
TI of 25.
Q5 Question 5 of 100
A patient with chronic pain is taking morphine and develops tolerance to the analgesic effect. The nurse
understands that pharmacodynamic tolerance is primarily caused by which mechanism?
A. Downregulation of opioid receptors in the central nervous system
B. Increased metabolic breakdown of the drug
C. Enhanced renal elimination of the drug
D. Decreased gastrointestinal absorption of the drug
Correct Answer: A
Rationale:
Pharmacodynamic tolerance results from downregulation or desensitization of receptors in response to chronic drug
exposure, requiring higher doses to achieve the same effect. Increased metabolic breakdown would represent
pharmacokinetic tolerance, not pharmacodynamic.
ve Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 - 2026/2027 | Passing Score: 8
, Q6 Question 6 of 100
A nurse is reviewing a patient's medication list and notes that Drug A is a CYP3A4 inhibitor while Drug B
is metabolized by CYP3A4. The nurse anticipates that concurrent administration will result in which
effect?
A. Increased levels of Drug B
B. Decreased levels of Drug B
C. No change in Drug B levels
D. Rapid elimination of Drug B
Correct Answer: A
Rationale:
A CYP3A4 inhibitor reduces the metabolic breakdown of drugs that depend on CYP3A4 for elimination, leading to
increased plasma levels of Drug B and potential toxicity. This is a common and clinically significant drug-drug
interaction.
Q7 Question 7 of 100
A patient is prescribed a medication with a half-life of 12 hours. The nurse understands that
approximately how long it will take to reach steady-state plasma concentrations with regular dosing?
A. 12 hours
B. 24 hours
C. 48 hours
D. 60 hours
Correct Answer: D
Rationale:
Steady-state plasma concentration is reached after approximately 4-5 half-lives of regular dosing. With a half-life of
12 hours, steady state would be reached in approximately 48-60 hours (4-5 x 12). The most accurate answer of the
choices is 60 hours.
Q8 Question 8 of 100
A nursing student asks why some drugs are administered as prodrugs. The instructor explains that
prodrugs are designed to serve which primary purpose?
A. To improve drug absorption, distribution, or targeting by becoming active after metabolism
B. To increase drug toxicity for enhanced therapeutic effect
C. To bypass all metabolic processes entirely
D. To reduce manufacturing costs of the medication
Correct Answer: A
Rationale:
Prodrugs are pharmacologically inactive compounds that are converted to active drugs through metabolic processes
in the body. This approach improves drug absorption, reduces side effects, or enables targeted delivery to specific
tissues.
ve Assessment Review (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 - 2026/2027 | Passing Score: 8
